The DOI matches its Crossref record; 36 of the 38 references it cites were found in a registry or an index.
Differential Functions of Growth Factor Receptor–Bound Protein 7 (GRB7) and Its Variant GRB7v in Ovarian Carcinogenesis
Abstract
Purpose Aberrant overexpression of growth factor receptor-bound protein 7 (GRB7) and its variant GRB7v has been found in numerous human cancers. The goal of this study was to characterize the functions of GRB7 and GRB7v in the ovarian carcinogenesis and to investigate the differential roles of GRB7 and GRB7v in the modulation of signaling pathways. Experimental design Quantitative reverse transcription-PCR, Western blot, and immunohistochemical analyses were used to evaluate the levels of GRB7 and GRB7v. The cellular localization, functions, and signaling pathways regulated by GRB7 and GRB7v were investigated by enforced expression of GRB7 and GRB7v. Results Quantitative reverse transcription-PCR and Western blot analyses showed that GRB7 and GRB7v were frequently upregulated in ovarian cancer samples. The overexpressed GRB7 (P = 0.009) and GRB7v (P = 0.017) were significantly correlated with high-grade ovarian cancer. Immunohistochemical analysis on ovarian cancer tissue array confirmed that the upregulated GRB7 was significantly correlated with high-grade ovarian cancer (P = 0.001). Confocal microscopy analysis showed that GRB7 and GRB7v predominately localized in cytoplasm of ovarian cancer cells, consistent with their roles as signaling adaptors. Enforced expression of GRB7 promoted cell proliferation, migration, and invasion, whereas GRB7v only increased cell proliferation and anchorage-independent growth ability. With the treatment of specific kinase inhibitors, we show…
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The inhibition of JNK, which is downstream of GRB7, displays synergy with the MEKi [37, 38].”
From Genome-wide CRISPR-cas9 knockout screening identifies GRB7 as a driver for MEK inhibitor resistance in KRAS mutant colon cancer (2022) · cites this paper as [38]
Citations
Cites
Hanahan, D., & Weinberg, R. A. (2000) · Cell · doi:10.1016/s0092-8674(00)81683-9 · Cited by 29,219
Rubin, M., & Stephen, C. D. (1993) · Cited by 3,149
Specificity in Signal Transduction
Pawson, T. (2004) · Cell · doi:10.1016/s0092-8674(03)01077-8 · Cited by 816
Cho, K. R., & Shih, I.-M. (2009) · Annual Review of Pathology: Mechanisms of Disease · doi:10.1146/annurev.pathol.4.110807.092246 · Cited by 694
Vang, R., Shih, I.-M., & Kurman, R. J. (2009) · Advances in Anatomic Pathology · doi:10.1097/pap.0b013e3181b4fffa · Cited by 562
Early Events in the Pathogenesis of Epithelial Ovarian Cancer
Landen, C. N., Birrer, M. J., & Sood, A. K. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2006.07.9970 · Cited by 462 · cited 1×
“Ovarian cancer is one of the most deadly malignancies in women (1).”
BackgroundStein, D., Wu, J., Fuqua, S. A., Roonprapunt, C., Yajnik, V., D'Eustachio, P., Moskow, J. J., Buchberg, A. M., Osborne, C. K., & Margolis, B. (1994) · The EMBO Journal · doi:10.1002/j.1460-2075.1994.tb06386.x · Cited by 249
Association of Focal Adhesion Kinase with Grb7 and Its Role in Cell Migration
Han, D. C., & Guan, J.-L. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.34.24425 · Cited by 225
Chan, D. W., Liu, V. W. S., Tsao, G. S. W., Yao, K.-M., Furukawa, T., Chan, K. K. L., & Ngan, H. Y. S. (2008) · Carcinogenesis · doi:10.1093/carcin/bgn167 · Cited by 215
Self-citationA novel family ofras-binding domains
Ponting, C. P., & Benjamin, D. R. (1996) · Trends in Biochemical Sciences · doi:10.1016/s0968-0004(96)30038-8 · Cited by 205
Cited by
Progress towards the development of SH2 domain inhibitors
Kraskouskaya, D., Duodu, E., Arpin, C. C., & Gunning, P. T. (2013) · Chemical Society Reviews · doi:10.1039/c3cs35449k · Cited by 119
Chen, K., Liu, M. X., Mak, C. S. L., Yung, M. M. H., Leung, T. H., Xu, D., Ngu, S., Chan, K. K. L., Yang, H., Ngan, H., et al. (2017) · Theranostics · doi:10.7150/thno.22377 · Cited by 86
Self-citationChu, P.-Y., Tai, Y.-L., & Shen, T.-L. (2019) · Cells · doi:10.3390/cells8050435 · Cited by 84
Yu, C., Luo, D., Yu, J., Zhang, M., Zheng, X., Xu, G., Wang, J., Wang, H., Xu, Y., Jiang, K., et al. (2022) · Oncogene · doi:10.1038/s41388-021-02077-w · Cited by 70
“The inhibition of JNK, which is downstream of GRB7, displays synergy with the MEKi [37, 38].”
BackgroundTargeted Ablation of miR-21 Decreases Murine Eosinophil Progenitor Cell Growth
Lu, T. X., Lim, E. J., Itskovich, S. S., Besse, J. A., Plassard, A. J., Mingler, M. K., Rothenberg, J. A., Fulkerson, P. C., Aronow, B. J., & Rothenberg, M. E. (2013) · PLoS ONE · doi:10.1371/journal.pone.0059397 · Cited by 59
Metadata
- Authors
- Wang, Y., Chan, D. W., Liu, V. W. S., Chiu, P., & Ngan, H. Y. S.
- Affiliations
- University of Hong Kong (HK)
- Authors' Affiliation: Department of Obstetrics and Gynecology, LKS Faculty of Medicine, The University of Hong Kong, Hong Kong SAR, People's Republic of China
- Venue
- Clinical Cancer Research
- Published
- 2010-04-28
- Volume
- 16
- Issue
- 9
- Pages
- 2529-2539
- ISSN
- 1078-0432 (ISSN-L)
- 1557-3265
- OpenAlex
- W2128428749
- Cited by
- 41
- References
- 38
- Citations by year
- 2024: 4 · 2023: 3 · 2021: 3 · 2020: 4 · 2019: 4 · 2017: 4 · 2016: 1 · 2015: 2 · 2014: 1 · 2013: 8 · 2012: 4
- FWCI
- 5.68
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Clinical Cancer Research (publishedVersion)
- PubMed (publishedVersion)
- The HKU Scholars Hub (University of Hong Kong) (submittedVersion)
- Topics
- Health Sciences › Medicine › Oncology › Ovarian cancer diagnosis and treatment
- Health Sciences › Medicine › Oncology › HER2/EGFR in Cancer Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Protein Kinase Regulation and GTPase Signaling
- Keywords
- Grb7, ovarian cancer, ovarian carcinogenesis, ERK signaling, JNK signaling, cell proliferation, cell migration and invasion, tumor grade, kinase inhibitors
- MeSH terms
- Anthracenes, Butadienes, Cell Line, Cell Movement, Cell Survival, Female, Humans, Immunohistochemistry, Middle Aged, Neoplasm Staging, Nitriles, Ovarian Neoplasms, Transfection, Blotting, Western, Signal Transduction, Gene Expression Regulation, Neoplastic, Alternative Splicing, Microscopy, Confocal, Protein Isoforms, Reverse Transcriptase Polymerase Chain Reaction, Mitogen-Activated Protein Kinases, Cell Line, Tumor, Cell Proliferation, Green Fluorescent Proteins, Proto-Oncogene Proteins c-akt, GRB7 Adaptor Protein
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Differential Functions of Growth Factor Receptor–Bound Protein 7 (GRB7) and Its Variant GRB7v in Ovarian Carcinogenesis. https://app.cochat.ai/papers/10.1158/1078-0432.ccr-10-0018
- The paper
- Wang, Y., Chan, D. W., Liu, V. W. S., Chiu, P., & Ngan, H. Y. S. (2010). Differential Functions of Growth Factor Receptor–Bound Protein 7 (GRB7) and Its Variant GRB7v in Ovarian Carcinogenesis. Clinical Cancer Research. https://doi.org/10.1158/1078-0432.ccr-10-0018
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.